- Issue of Convertible Loan Notes & Board Changes
- Midkine Antibody Licencing Deal
- Annual Report & Financial Statements - 31 Dec 2023
- Response to Share Price Movement
- Positive Results: Midkine mRNA and STAT-6 siRNA
- Operations Update
- Change of Auditor
- Significant Mesodermal Killer Cell Milestone
- Interim Results to 30 June 2023
- Investor Presentation via Investor Meet Company
More ▼
Key statistics
On Thursday, Roquefort Therapeutics PLC (ROQ:LSE) closed at 5.50, 42.86% above the 52 week low of 3.85 set on Apr 05, 2024.
52-week range
Open | 5.50 |
---|---|
High | 4.30 |
Low | 5.30 |
Bid | 5.00 |
Offer | 8.00 |
Previous close | 5.50 |
Average volume | 457.91k |
---|---|
Shares outstanding | 129.15m |
Free float | 37.48m |
P/E (TTM) | -- |
Market cap | 5.75m GBP |
EPS (TTM) | -- |
Data delayed at least 20 minutes, as of May 23 2024 16:35 BST.
More ▼